METHOD FOR COMPLEX TREATMENT OF HEMODYNAMIC DISORDERS OF BULBAR CONJUNCTIVA OF PATIENTS WITH COVID-19 ASSOCIATED PNEUMONIA Russian patent published in 2021 - IPC G01N33/569 A61K31/385 A61K31/196 A61K31/4412 A61P27/02 

FIELD: medicine; ophthalmology.

SUBSTANCE: invention relates to the field of medicine, namely to ophthalmology, it can be used for the complex treatment of hemodynamic disorders of the bulbar conjunctiva of persons who have suffered COVID-19 associated pneumonia. The method includes biomicroscopy of the bulbar conjunctiva. In the presence of intravascular changes in the form of a Sludge phenomenon, paravasal changes in the form of single hemorrhages, the level of low-density cholesterol lipoproteins is determined. If the value is greater than 3.0 mmol/l, the basic therapy of dyslipidemia is performed, 600 mg thioctic acid tablets are prescribed once a day for 3 months, bromfenac solution is instilled in both eyes 1 drop 2 times a day for 1 month and 1% emoxipine solution is instilled three times a day for 3 months.

EFFECT: use of the invention makes it possible to correct hemodynamic disorders of the conjunctiva, to improve the quality of life of patients who have suffered COVID-19 associated pneumonia by comprehensively treating hemodynamic disorders of the bulbar conjunctiva in the early recovery period.

1 cl, 2 ex